Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Doshi

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
BMJ (Clinical Research Ed.)|January 8, 2016
Defining antibiotic effectiveness and resistance: how a private party may soon rule judgments over susceptibility testingPeter Doshi
BMJ (Clinical Research Ed.)|February 16, 2018
CDC tightens controls on scientists' communication with news mediaPeter Doshi
BMJ (Clinical Research Ed.)|May 15, 2023
Did the FDA break its own rules in approving the antibiotic Recarbrio?Peter Doshi
BMJ (Clinical Research Ed.)|April 15, 2026
Multiple sclerosis: Could Roche's bestselling drug Ocrevus be doing more harm than good in women with primary progressive MS?Peter Doshi
BMJ (Clinical Research Ed.)|April 9, 2016
Convicting ZikaPeter Doshi
BMJ (Clinical Research Ed.)|February 9, 2017
Medical response to Trump requires truth seeking and respect for patientsPeter Doshi
BMJ (Clinical Research Ed.)|May 19, 2021
Covid-19 vaccines: In the rush for regulatory approval, do we need more data?Peter Doshi
BMJ (Clinical Research Ed.)|September 10, 2017
The problem with US website for collecting adverse events after vaccination is resolvedPeter Doshi
BMJ (Clinical Research Ed.)|November 9, 2017
The unofficial vaccine educators: are CDC funded non-profits sufficiently independent?Peter Doshi
BMJ (Clinical Research Ed.)|March 22, 2018
EMA recommendation on hydroxyethyl starch solutions obscured controversyPeter Doshi
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
BMJ (Clinical Research Ed.)|January 8, 2016
Defining antibiotic effectiveness and resistance: how a private party may soon rule judgments over susceptibility testingPeter Doshi
BMJ (Clinical Research Ed.)|February 16, 2018
CDC tightens controls on scientists' communication with news mediaPeter Doshi
BMJ (Clinical Research Ed.)|May 15, 2023
Did the FDA break its own rules in approving the antibiotic Recarbrio?Peter Doshi
BMJ (Clinical Research Ed.)|April 15, 2026
Multiple sclerosis: Could Roche's bestselling drug Ocrevus be doing more harm than good in women with primary progressive MS?Peter Doshi
BMJ (Clinical Research Ed.)|April 9, 2016
Convicting ZikaPeter Doshi
BMJ (Clinical Research Ed.)|February 9, 2017
Medical response to Trump requires truth seeking and respect for patientsPeter Doshi
BMJ (Clinical Research Ed.)|May 19, 2021
Covid-19 vaccines: In the rush for regulatory approval, do we need more data?Peter Doshi
BMJ (Clinical Research Ed.)|September 10, 2017
The problem with US website for collecting adverse events after vaccination is resolvedPeter Doshi
BMJ (Clinical Research Ed.)|November 9, 2017
The unofficial vaccine educators: are CDC funded non-profits sufficiently independent?Peter Doshi
BMJ (Clinical Research Ed.)|March 22, 2018
EMA recommendation on hydroxyethyl starch solutions obscured controversyPeter Doshi
Pageof 15